Authors: van den Bogaard, R Fijen, CAP Schipper, MGJ de Galan, L Kuijper, EJ Mannens, MMAM

Citation: R. Van Den Bogaard et al., Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies, EUR J HUM G, 8(7), 2000, pp. 513-518

Authors: Fijen, CAP Bredius, RGM Kuijper, EJ Out, TA De Haas, M De Wit, APM Daha, MR De Winkel, JGJ

Citation: Cap. Fijen et al., The role of Fc gamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals, CLIN EXP IM, 120(2), 2000, pp. 338-345

Authors: Drogari-Apiranthitou, M Fijen, CAP Van De Beek, D Hensen, EF Dankert, J Kuijper, EJ

Citation: M. Drogari-apiranthitou et al., Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients, CLIN EXP IM, 119(2), 2000, pp. 311-316

Authors: Fijen, CAP Kuijper, EJ Bulte, MTT Daha, MR Dankert, J

Citation: Cap. Fijen et al., Assessment of complement deficiency in patients with meningococcal diseasein the Netherlands, CLIN INF D, 28(1), 1999, pp. 98-105

Authors: Fijen, CAP van den Bogaard, R Schipper, M Mannens, M Schlesinger, M Nordin, FG Dankert, J Daha, MR Sjoholm, AG Truedsson, L Kuijper, EJ

Citation: Cap. Fijen et al., Properdin deficiency: molecular basis and disease association, MOL IMMUNOL, 36(13-14), 1999, pp. 863-867

Authors: Fijen, CAP Kuijper, EJ Drogari-Apiranthitou, M Van Leeuwen, Y Daha, MR Dankert, J

Citation: Cap. Fijen et al., Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine, CLIN EXP IM, 114(3), 1998, pp. 362-369